All Stories

  1. Neuroinflammatory reactive astrocyte formation correlates with adverse outcomes in perinatal white matter injury
  2. All but Small: miRNAs from Wharton’s Jelly-Mesenchymal Stromal Cell Small Extracellular Vesicles Rescue Premature White Matter Injury after Intranasal Administration
  3. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
  4. MicroRNA Cargo in Wharton’s Jelly MSC Small Extracellular Vesicles: Key Functionality to In Vitro Prevention and Treatment of Premature White Matter Injury
  5. Hyperuricemia during Pregnancy Leads to a Preeclampsia-Like Phenotype in Mice
  6. Intranasally Administered Exosomes from Umbilical Cord Stem Cells Have Preventive Neuroprotective Effects and Contribute to Functional Recovery after Perinatal Brain Injury
  7. Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury
  8. In vitro-microenvironment directs preconditioning of human chorion derived MSC promoting differentiation of OPC-like cells
  9. Extracellular Vesicles Derived from Wharton’s Jelly Mesenchymal Stem Cells Prevent and Resolve Programmed Cell Death Mediated by Perinatal Hypoxia-Ischemia in Neuronal Cells
  10. 797: Wharton's jelly stem cell-derived extracellular vesicles drive neural progenitor cells towards oligodendroglial identity
  11. 798: Intranasal administration of extracellular vesicles derived from human umbilical cord mesenchymal stem cells as a potential treatment for perinatal brain damage
  12. Mesenchymal stromal cells from umbilical cord Wharton's jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact
  13. Wharton's Jelly Mesenchymal Stem Cells Protect the Immature Brain in Rats and Modulate Cell Fate
  14. 394: Neuro-protective and -regenerative effects of exosomes derived from Wharton's jelly mesenchymal stem cells
  15. Intranasal Delivery of Umbilical Cord-Derived Mesenchymal Stem Cells Preserves Myelination in Perinatal Brain Damage
  16. Mesenchymal stem/stromal cells—a key mediator for regeneration after perinatal morbidity?
  17. Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid
  18. 364: Neuroregenerative functions of transnasal delivered umbilical cord stem cells in a model of preterm hypoxic-ischemic brain injury
  19. PreImplantation Factor bolsters neuroprotection via modulating Protein Kinase A and Protein Kinase C signaling
  20. 294: Umbilical cord stem cells prime neural progenitor cells towards an oligodendrocyte fate
  21. 53: Successful transnasal delivery of stem cells in a rat model of perinatal hypoxic-ischemic brain injury
  22. 106: Synthetic preimplantation factor (sPIF*) promotes neuroprotection by modulating PKA/PKC kinases
  23. PreImplantation factor promotes neuroprotection by targeting microRNA let-7
  24. Umbilical Cord Stem Cells Induce Glial Fate in Neural Progenitor Cells
  25. Preeclampsia enhances neuroglial marker expression in umbilical cord Wharton's jelly-derived mesenchymal stem cells
  26. 786: Neurotrophic factors from human Wharton’s jelly mesenchymal stem cells induce gliogenesis
  27. 785: Neuroprotective role of Wharton’s jelly-derived mesenchymal stem cells in encephalopathy of prematurity (rat model)
  28. Stem Cells From Umbilical Cord Wharton’s Jelly From Preterm Birth Have Neuroglial Differentiation Potential
  29. 183: Human Wharton's jelly-derived mesenchymal stem cells express neurotrophic factors in vitro
  30. 432: Mesenchymal stem cell therapy of hypoxi/ischaemic brain damage
  31. O480 INTRACRANIAL MESENCHYMAL STEM CELL THERAPY IN A PERINATAL BRAIN DAMAGE MODEL
  32. Intrakraniale Stammzelltransplantation mit und ohne Erythropoietin erleichert die motorische Wiederherstellung bei perinataler Hirnschädigung im Rattenmodell
  33. 436: Preconditioning of chorion derived mesenchymal stem cells by different culture conditions for subsequent neural differentiation
  34. 54: Early intracranial mesenchymal stem cell therapy after a perinatal rat brain damage
  35. 428: Intracranial stem cell transplantation with and without erythropoietin facilitates motor recovery in a perinatal rat brain injury model
  36. 60: Umbilical cord Whartons jelly-derived mesenchymal stem cells have neural differentiation potential
  37. Placenta-derived Mesenchymal Stem Cells for the Neuroregeneration in a Rat Perinatal Brain Injury Model
  38. Homing of placenta-derived mesenchymal stem cells after perinatal intracerebral transplantation in a rat model
  39. Stammzelltransplantation bei Perinataler Hirnschädigung im Rattenmodell: Migration, Homing und Integration
  40. 399: Neural differentiation potential of human umbilical cord Whartons jelly-derived cells
  41. 400: Human embryonic stem cell-derived neuronal and oligodendrocyte progenitors are donor cell graft candidates for perinatal neuroregeneration
  42. 60: Engraftment of human placental-derived mesenchymal stem cells after intracerebral transplantation for neuroregeneration in a rodent model of perinatal brain injury
  43. Generation of an Osteogenic Graft From Human Placenta and Placenta-Derived Mesenchymal Stem Cells
  44. Perinatal Stem Cell Therapy
  45. Turning placenta into brain: placental mesenchymal stem cells differentiate into neurons and oligodendrocytes
  46. Fetal gene therapy: Opportunities and risks
  47. Placenta mesenchymal stem cells on a chorion scaffold as a potential osteogenic graft for peripartal bone regeneration
  48. Perinatal stem-cell and gene therapy for hemoglobinopathies
  49. Placental mesenchymal stem cells as potential grafts for peripartum osteogenic and neural regeneration
  50. 67: Placenta stem cells as autologous grafts for peripartum neuroregeneration - the neural differentiation potential of human placental mesenchymal stem cells
  51. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration
  52. Tissue-specific engraftment after in utero transplantation of allogeneic mesenchymal stem cells into sheep fetuses
  53. Simvastatin and vitamins C and E reduce a marker for atherosclerosis and endothelial activation
  54. Tissue-specific engraftment of mesenchymal stem cells after in-utero transplantation in ovine fetuses
  55. Engraftment Kinetics of Human Cord Blood and Murine Fetal Liver Stem Cells Following In Utero Transplantation into Immunodeficient Mice
  56. In utero transplantation of autologous and allogeneic fetal liver stem cells in ovine fetuses
  57. In utero transplantation of autologous and allogeneic fetal liver stem cells in fetal sheep
  58. Homing und Engraftment von autologen versus allogenen Stammzellen nach intrauteriner Transplantation im fetalen Schaf
  59. Engraftment of human cord blood-derived stem cells in preimmune ovine fetuses after ultrasound-guided in utero transplantation
  60. Ultrasound-guided stem cell sampling from the early ovine fetus for prenatal ex vivo gene therapy
  61. 512 Stem cell sampling from the first trimester fetus for prenatal ex-vivo gene therapy: Feasibility study
  62. Heat Shock Protein Upregulation Lowers Cytokine Levels after Ischemia and Reperfusion
  63. Scaffold Precoating with Human Autologous Extracellular Matrix for Improved Cell Attachment in Cardiovascular Tissue Engineering
  64. Expression of adhesion molecules and cytokines after coronary artery bypass grafting during normothermic and hypothermic cardiac arrest
  65. Tissue engineering in cardiovascular surgery: new approach to develop completely human autologous tissue
  66. Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults
  67. Tissue Engineering of a Bioprosthetic Heart Valve
  68. Tissue engineering in cardiovascular surgery: MTT, a rapid and reliable quantitative method to assess the optimal human cell seeding on polymeric meshes1
  69. SCAFFOLD PRECOATING WITH HUMAN AUTOLO­GOUS EXTRACELLULAR MATRIX FOR IMPROVED CELL ATTACHMENT IN CARDIOVASCULAR TISSUE ENGINEERING
  70. Fluorescence activated cell sorting: A reliable method in tissue engineering of a bioprosthetic heart valve
  71. Lazaroid donor pretreatment does not improve lung allograft reperfusion injury in swine
  72. Tissue engineering: A new approach in cardiovascular surgery; Seeding of human fibroblasts followed by human endothelial cells on resorbable mesh1
  73. A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
  74. Construction and Characterization of a 10-Genome Equivalent Yeast Artificial Chromosome Library for the Laboratory Rat,Rattus norvegicus
  75. Characterization of a set of variable number of tandem repeat markers conserved in Bovidae